EDAP TMS S.A. (EDAP): this can see 20 a share on FDA approval...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	670
Posts	86163
Boards Moderated	0
Alias Born	05/25/2008

The Night Stalker

Re: Talc Moan post# 759

Thursday, 12/19/2013 10:34:13 AM

Thursday, December 19, 2013 10:34:13 AM

this can see 20 a share on FDA approval in Q1 2014

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent EDAP News

Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:05:13 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/01/2026 04:15:11 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/31/2026 08:55:52 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/25/2026 08:25:10 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:15:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 11:30:10 AM
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference • GlobeNewswire Inc. • 03/10/2026 11:30:00 AM
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 • GlobeNewswire Inc. • 03/04/2026 12:30:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 10:59:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 12:30:27 PM
EDAP Announces Appointment of David Horn to Board of Directors • GlobeNewswire Inc. • 02/12/2026 12:30:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 09:05:55 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 09:05:14 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 08:31:52 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 08:28:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:30:36 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 01:07:23 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 01:06:12 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 11:37:41 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 11:36:00 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 12:33:04 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/18/2025 11:05:13 AM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2025 12:31:05 PM
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation • PR Newswire (US) • 10/17/2025 01:50:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent EDAP News

More EDAP News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent EDAP News

Go Ad-Free